In this study, we examined the role of the E-cadherinrepressed gene human Nanos1 (hNanos1) in tumor invasion process. First, our in vivo study revealed that hNanos1 mRNAs were overexpressed in invasive lung carcinomas. Moreover, hNanos1 was co-localized with MT1-MMP (membrane type 1-matrix metalloproteinase) in E-cadherin-negative invasive lung tumor clusters. Using an inducible Tet-on system, we showed that induction of hNanos1 expression in DLD1 cells increased their migratory and invasive abilities in a three-dimensional migration and in a modified Boyden chamber assay. Accordingly, we demonstrated that hNanos1 upregulated MT1-MMP expression at the mRNA and protein levels. Inversely, using an RNA interference strategy to inhibit hNanos1 expression in invasive Hs578T, BT549 and BZR cancer cells, we observed a downregulation of MT1-MMP mRNA and protein and concomitantly a decrease of the invasive capacities of tumor cells in a modified Boyden chamber assay. Taken together, our results demonstrate that hNanos1, by regulating MT1-MMP expression, plays an important role in the acquisition of invasive properties by epithelial tumor cells.
Introduction
E-cadherin, a cell surface adhesion molecule essential for maintaining the structural integrity of epithelial tissue, has been previously characterized as a tumor/ invasion suppressor. The loss of intercellular adhesion caused by dysfunction of the E-cadherin/catenin complex is correlated with the acquisition of an invasive phenotype (Behrens et al., 1993) . The in vitro reexpression of E-cadherin by transfection in highly invasive tumor cells reduces their invasive potential (Frixen et al., 1991; Vleminckx et al., 1991; Mareel et al., 1996; Nawrocki-Raby et al., 2003) . Recently, Strumane et al. (2006) have reported that E-cadherin represses human Nanos1 (hNanos1). Indeed, E-cadherin reexpression in invasive tumor cells results in the downregulation of hNanos1, and high hNanos1 expression was described only in E-cadherin-deficient tumor cell lines. Nanos and nanos-related proteins are characterized by the presence of a conserved C-terminal (CCHC) 2 zinc-finger RNA-binding domain (Mosquera et al., 1993) . Nanos proteins are involved in the regulation of various development processes. In Drosophila, nanos regulates differentiation of the anterior-posterior body axis, primordial germ cell migration, oogenesis and spermatogenesis (Wang and Lehmann, 1991; Wang et al., 1994; Kobayashi et al., 1996; Forbes and Lehmann, 1998; Bhat, 1999; Deshpande et al., 1999) . hNanos1 is abundant in germ-line stem cells (Jaruzelska et al., 2003) . In tumor, it has also been demonstrated that the E-cadherin-repressed gene hNanos1 is involved in the acquisition of invasive properties by inducing disruption of cell-cell adhesion, cell dispersion and increased migratory and invasive behavior (Strumane et al., 2006) . The mechanism by which hNanos1 mediates these functions is, however, not known.
Several in vitro studies have shown that E-cadherin's function as a tumor invasion suppressive resides not only in its participation in cell-cell contacts, but also in its ability to sequester to the cell membrane several cotranscriptional factors (catenins) which can themselves modulate the expression of invasion-associated genes. Among them, matrix metalloproteinases (MMPs) have recently been identified (Behrens, 2005) . Indeed, in vitro and in vivo data have shown an inverse correlation between E-cadherin and MMPs (Kitadai et al., 1996; Polette et al., 1998) , and the re-expression of E-cadherin has been described to repress MMP expression in invasive cancer cells (Luo et al., 1999; Ara et al., 2000; Nawrocki-Raby et al., 2003) . MMPs comprise a large family of zinc-dependent endopeptidases that share common structural features and can degrade almost all extracellular matrix (ECM) components. MMP overexpression via the deregulation of the ratio between MMPs and their specific inhibitors TIMPs (tissue inhibitors of MMPs) is indeed correlated with tumor aggressiveness and poor clinical outcome (Chang and Werb, 2001 ). MT1-MMP (membrane type 1-MMP) is essentially characterized as a major physiological activator of MMP-2. In addition to its role, MT1-MMP can also degrade structural ECM components, cell adhesion molecules and some cytokines (Seiki, 2003) . Several studies have found that MT1-MMP is overexpressed in many types of human carcinomas (Seiki, 2003) . Moreover, numerous reports have reported that MT1-MMP is associated with the acquisition of an invasive phenotype by tumor cells . Interestingly, MT1-MMP expression in epithelial tumor cells has been shown to correlate with and to be regulated by a reorganization of adhesion molecule complexes (Takahashi et al., 2002; Hlubek et al., 2004; Polette et al., 2005) . These data stress that cell-cell adhesion molecules play a role in the regulation of tumor invasion-associated genes such as MMPs.
In this study, we analysed the expression of hNanos1 in human tumor samples and examined the potential role of the E-cadherin-repressed gene hNanos1 on MT1-MMP expression. Accordingly, we analysed the effects of hNanos1 conditional overexpression or RNAi knockdown on expression of MT1-MMP expression and on invasive properties of tumor cell lines.
Results

hNanos1 is highly expressed in lung carcinomas
By reverse transcription (RT)-PCR analysis, we found that hNanos1 is expressed significantly more in lung carcinomas than in normal lung tissues ( Figure 1a) . We also observed a significant correlation between the hNanos1 mRNA and tumor aggressiveness according to the tumor node metastasis (TNM) classification. Indeed, in stage II/III tumor samples hNanos1 mRNA is expressed more than in stage I tumor samples (Figure 1b) . Moreover, patients with a low level of hNanos1 mRNA tend to survive longer than those with a high level (Supplementary Figure 1) . hNanos1 mRNAs were detected by in situ hybridization in tumor cells of squamous-cell and adenocarcinomas. The tumor cells located at the invading front of the tumor clusters were the most strongly labeled (Figure 2a) . Some positivities were also observed in inflammatory stromal cells in some tumors. By immunohistochemistry analysis, the hNanos1 protein was mostly detected in invasive tumor cells (Figure 2b) .
The co-immunodetection of E-cadherin, hNanos1 and MT1-MMP on serial lung tumor sections allowed to observe that hNanos1 and MT1-MMP were preferentially co-expressed in E-cadherin-negative tumor areas ( Figure 3 ).
hNanos1 promotes cell migration and invasion
To study the function of hNanos1 in the tumor invasion process, we used a human epithelial cancer cell system with inducible expression of Myc-tagged hNanos1. Addition of doxycycline (dox) induces tagged hNanos1 in DLD1-Teton-hNanos1 cells, but not in DLD1-Tetonmock cells as demonstrated by immunofluorescence (Figure 4a ). First, we tested the effect of hNanos1 expression on the migratory properties of tumor cells in a three-dimensional culture system. We observed length of higher trajectories for hNanos1-expressing cells compared with control cells (Figure 4b ). We demonstrated that the induction of hNanos1 expression significantly increases the migration speeds of DLD1 cells along the x-y-z planes (Po0.05) (Figures 4c) .
The role of hNanos1 in the acquisition of invasive properties by tumor cells was further examined in modified Boyden chamber assay. We observed that both the doxycycline-treated and the non-induced DLD1-Teton-mock displayed similar invasive capacities, whereas the doxycycline-treated hNanos1-expressing DLD1-Teton-hNanos1 cells were significantly more invasive than untreated cells (1.45-fold, Po0.05) (Figure 5a ). Moreover, addition of the synthetic MMP inhibitor BB-94 totally abolished the hNanos1-induced invasion of the doxycycline-treated DLD1-Teton-hNanos1 cells (Po0.05). In contrast, BB-94 had no effect on invasiveness of the doxycycline-treated DLD1-Teton-mock, -untreated DLD1-Teton-mock or -untreated DLD1-Teton-hNanos1 cells ( Figure 5a ). These results demonstrate that MMPs are implicated in hNanos1-mediated invasiveness of DLD1 cells expressing hNanos1.
hNanos1 regulates MT1-MMP expression
To evaluate the potential implication of hNanos1 in the regulation of MT1-MMP expression, we first analysed MMP production in untreated and doxycycline-treated DLD1-Teton-mock and DLD1-Teton-hNanos1 cells.
RT-PCR analysis revealed that induction of hNanos1 
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A Bonnomet et al expression led to 1.5-fold increase in the mRNA levels of MT1-MMP (Po0.05) (Figure 5b ). Doxycycline treatment had no effect on MT1-MMP mRNA production by the DLD1-Teton-mock cells. No significant variation of TIMP-1 and TIMP-2 mRNA levels was observed (data not shown). We further tested production of MT1-MMP by western blotting. We observed that doxycycline-treated DLD1 hNanos1 transfectants produced a significantly higher level of the 60-kDa active form of MT1-MMP (1.5 ± 0.2-fold, Po0.01) (Figure 5c ). These results were confirmed by the quantitative determination of active MT1-MMP that revealed a 
A Bonnomet et al 2.38 ± 0.54-fold increase of MT1-MMP activity after doxycycline induction of hNanos1 expression in DLD1 hNanos1 transfectants (Po0.05) (Figure 5d ). We also tested the effects of two hNanos1-specific siRNAs on MT1-MMP production in the hNanos1-positive Hs578T, BT549 and BZR invasive tumor cells. We observed a significant decrease of MT1-MMP mRNA following transfection of the hNanos1 siRNA (for MT1-MMP: 0.54-, 0.79-and 0.65-fold for hNanos1si1, 0.31-, 0.54-and 0.44-fold for hNanos1si2 in BT549, Hs578T and BZR, respectively) ( Figure 6a ). Such a decrease was also observed at the protein level (0.72-, 0.66-and 0.62-fold for hNanos1si1, 0.64-, 0.51-and 0.47-fold for hNanos1si2 in BT549, Hs578T and BZR, respectively) ( Figure 6b ).
Concomitantly, we tested the effect of hNanos1 silencing on the invasive capacities of BT549, Hs578T and BZR tumor cells in the Boyden chamber assay. We observed that the two hNanos1 siRNAs significantly reduced the invasive properties of the BT549, Hs578T and BZR cells (0.54-, 0.56-and 0.57-fold for hNanos1si1 and 0.47-, 0.45-and 0.54-fold for hNanos1si2 in BT549, Hs578T and BZR, respectively) ( Figure 6c ).
Discussion
In this study, we demonstrated that (1) the newly identified E-cadherin-repressed gene hNanos1 is overexpressed in human invasive lung carcinomas and (2) hNanos1 expression regulates the production of MT1-MMP and the concomitant MMP-dependent invasion of carcinoma cells.
We found that hNanos1 is overexpressed in human lung carcinoma samples compared to normal lung tissue. Moreover, its expression is correlated with tumor aggressiveness according to the TNM classification. We also observed that hNanos1 is produced by invasive carcinoma cells. Thus, these results suggest that this gene is implicated in tumor invasion. This is in agreement with our data showing that the expression of hNanos1 promotes the in vitro invasive abilities of 
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DLD1-Teton-hNanos1 cells and that the downregulation of hNanos1 levels by siRNA clearly decreases the in vitro invasiveness of tumor cells. Accordingly, a previous study has reported that hNanos1 expression induces cell dispersion as well as invasion in collagen type I gels, and increases the migration speed of tumor cells (Strumane et al., 2006) . Here, we also demonstrated that hNanos1 induces DLD1 invasiveness in an MMPdependent manner by using a Boyden chamber assay. We further observed that the forced expression of hNanos1 in DLD1 tumor cells increases MT1-MMP expression at both the mRNA and protein levels, indicating a causal relation between hNanos1 expression and invasion. These data are strengthened by the in vivo co-localization of hNanos1 and MT1-MMP in Ecadherin-negative tumor clusters. Inversely, transfection of hNanos1-specific siRNAs in invasive BT549, Hs578T and BZR tumor cells decreases their MT1-MMP expression. In line with our findings, MT1-MMP has already been described as one of the major MMPs involved in migration and invasion processes. It has been repeatedly reported that overexpression of MT1-MMP correlates with malignant progression of many human cancer types (Polette et al., 2004) . Moreover, in vitro observations have shown that MT1-MMP is associated with the invasive behavior of epithelial tumor cell lines . We also showed that TIMP-1 and TIMP-2 expression is not affected, thus emphasizing that hNanos1 provokes disruption of the balance between MT1-MMP and its inhibitor in favor of a high proteolytic activity. Taken together, these data indicate that hNanos1 upregulates the production of MT1-MMP to promote tumor cell invasion.
The signaling cascade by which hNanos1 regulates the expression of tumor invasion-associated genes, such as MT1-MMP, remains unclear. The interactions between hNanos1 and several partners could be essential for the functions of this molecule. In Drosophila, nanos is recruited by pumilio to bind to nanos-responsive elements located in the 3 0 untranslated region of target transcripts, for example, hunchback and cyclin B mRNAs (Murata and Wharton, 1995; Asaoka-Taguchi et al., 1999; Sonoda and Wharton, 2001 ). The structure of pumilio reveals the presence of a Puf domain containing helical repeats (PUM repeats) and showing homology with armadillo-repeat domains (Edwards et al., 2001) . Among the armadillo-related proteins, the catenin p120ctn has been recently shown to interact with the N-terminal domain of hNanos1 (Strumane et al., 2006) . p120ctn has been implicated in the regulation of E-cadherin turnover at the cell membrane, thereby playing a key role in the control of cell-cell adhesive properties (Hatzfeld, 2005) . In cells lacking E-cadherin, the cytoplasmic and nuclear pools of p120ctn have been implicated in tumor progression (Reynolds and Roczniak-Ferguson, 2004) . Indeed, it has been shown that cytoplasmic p120ctn accumulation affects Rho GTPase activities leading to an increase of cell invasiveness (Reynolds and Roczniak-Ferguson, 2004 ). In the other hand, Strumane et al. (2006) have suggested that hNanos1 may intervene in this 
A Bonnomet et al p120ctn-mediated Rho GTPase signaling. Furthermore, a recent study has demonstrated that the MT1-MMPdependent invasion of melanoma cells induced by CXCL12 involves Vav/Rho GTPase signaling (Bartolome et al., 2006) . All these data indicate that the interactions between hNanos1 and its identified or potential partners could be implicated in the regulation of tumor-associated genes such as MT1-MMP.
In conclusion, the present study demonstrates that hNanos1 contributes to tumor cell invasion by modulating MT1-MMP expression. Our results also suggest a new mechanism of E-cadherin-mediated MMP regulation in which invasion-inducing hNanos1 could play a central role.
Materials and methods
Tumor tissue samples
The human tissues were obtained from 49 lungs resected for carcinomas (28 squamous cell carcinomas and 21 adenocarcinomas) of stages I (16 cases), II (17 cases) and III (16 cases) according to TNM classification, and from 27 normal lung tissues matching the tumor samples.
Tumor cell lines
Hs578T, BT549 and BZR were obtained from the American Type Culture Collection (Rockville, MD, USA). DLD1-Teton-hNanos1 cells (Strumane et al., 2006 ) express a Myctagged hNanos1 protein when treated with doxycycline (dox) at a concentration of 2 mg ml À1 (Sigma, St Louis, MO, USA). DLD1-Teton-mock cells, without or with doxycycline treatment, and DLD1-Teton-hNanos1 without doxycycline treatment, were used as negative controls.
Transfection of small interfering RNA Two hNanos1-specific 19-nt sequences were selected in the coding sequence of hNanos1 (GenBank accession number: NM199461) to generate 21-nt sense and 21-nt antisense strands of the type (19N) TT (N, any nucleotide) . The selected 19-nt sequences were as follow: hNanos1si1, 5 0 -GCCCGAGCUG CAGGUGUGC-3 0 ; hNanos1si2, 5 0 -CGCGCACACCAUC AAGUAC-3 0 (Eurogentec, Seraing, Belgium). A total of 75 000 cells were transfected with 20 nM siRNA duplexes by calcium phosphate-precipitation method. Twenty four hours Thirty fields ( Â 400) were counted on each filter. Data are expressed as fold induction for hNanos1 siRNA transfectants (si1 and si2) relative to the control siRNA transfectants (cont1 and cont2) (*Po0.05, **Po0.01, ***Po0.001).
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RT-PCR analysis RNA was extracted from normal and tumor lung tissues frozen in liquid nitrogen with the RNA Easy Qiagen kit (Qiagen GmbH, Hilden, Germany) and from tumor cell lines with the High Pure RNA isolation kit (Roche diagnostics GmbH, Manheim, Germany). RT-PCR was performed with 10 ng of total RNA by using the Thermostable rTth Reverse Transcriptase RNA PCR kit (Applied Biosystem, Foster City, CA, USA) and six pairs of nucleotides (Eurogentec). Forward and reverse primers for hNanos1, MT1-MMP and 28S rRNA were designed as follows: hNanos1 primers (forward 5 0 -TCTT AACCCCAGACCAGAGA-3 0 , reverse 5 0 -ATACTCTCCTG CCCTCAAGA-3 0 ), MT1-MMP primers (forward 5 0 -GGAT ACCCAATGCCCATTGGCCA-3 0 , reverse 5 0 -CCATTGGGC ATCCAGAAGAGAC-3 0 ) and 28S primers (forward 5 0 -G TT CACCCACTAATAGGGAACGTGA-3 0 , reverse 5 0 -GGATT CTGACTTAGAGGCGTTCAGT-3 0 ). RT-PCR analysis was done in the linear phase of amplification by using a limited number of PCR cycles. RT-PCR products were separated by acrylamide gel electrophoresis stained with SYBR Gold (Molecular Probes, Eugene, OR, USA) and quantified by fluorimetric scanning (LAS-1000; Fuji, Stamford, CT, USA).
In situ hybridization The pCS2-Myctag-hNanos1 (Strumane et al., 2006) was used to generate fluorescein-12-UTP-labeled sense and anti-sense hNanos1 RNA probes with the Fluorescein RNA labeling mix (Roche). About 15 ml of sense or anti-sense probe diluted to 1.5 ng ml À1 in mRNA in situ hybridization solution (DakoCytomation, Carpinteria, CA, USA) were applied on each 5 mm cryosections. Hybridization was carried out overnight at 63 1C. After washes in Tris-buffered saline/Tween at RT and one bath in a Stringent wash (DakoCytomation) for 30 min at 75 1C, the detection was performed using the GenPoint fluorescein kit (DakoCytomation). Peroxydase activity was revealed with AEC (3-amino-9-ethylcarbazole) chromogen (DakoCytomation). Slides were counterstained with Mayer's haematoxylin.
Immunohistochemistry
Immunohistochemistry for hNanos1 was done on paraffin serial sections. After antigen retrieval pretreatment in citrate buffer, slides were incubated with either a goat polyclonal antibody to hNanos1 (2.5 mg ml À1 ) (ab36163, lot 251467; Abcam, Cambridge, UK), a mouse monoclonal antibody to human E-cadherin (clone 36; Transduction Laboratories, Lexington, UK) or a goat polyclonal antibody to human MT1-MMP (AF918; R&D systems, Abingdon, UK). Subsequent steps were performed with the LSAB þ system-AP kit (DakoCytomation). Alkaline phosphatase activity was revealed with fuschin þ substrate-chromogen (DakoCytomation). Slides were counterstained with Mayer's haematoxylin.
Immunofluorescence Subconfluent monolayers of DLD1 transfectants cultured on glass coverslips were fixed with cold methanol. Monolayers were incubated with a mouse monoclonal antibody 9E10 against Myc-tag (1:500; Sigma) and next were exposed to Alexa594-coupled anti-mouse IgG (1:200; Molecular Probes). Nuclei were stained with Dapi (Molecular Probes).
Three-dimensional culture model and computer-assisted videomicroscopy A two-layer type I collagen gel was prepared on Transwell (Corning, NY, USA). A total of 2.5 Â 10 4 DLD1 transfectants were incorporated in the second collagen gel layer. Cell migration analysis was performed using an inverted microscope (Axiovert 200; Zeiss, Oberkochen, Germany) equipped with an environmental chamber (Climabox; Zeiss) with 5% CO 2 in air at 37 1C and driven by the Metamorph software (Roper scientific, photometrics, Tucson, AZ, USA). Image sequences of the cells within the collagen gel were recorded every hour at least 150 successive Z levels at Â 10 magnification with a charge-coupled device camera (Coolsnap; Roper Scientific). The migratory behavior of the cells was finally analysed by using a cell-tracking software developed in our laboratory, which allows the three-dimensional representation of the trajectories and the migration speed quantitation in x-y-z plane as described by Hazgui et al. (2005) .
Modified Boyden chamber invasion assay
The in vitro invasive properties of transfected cells were assessed using a modified Boyden chamber assay. DLD1 transfectants (10 5 cells), as well as invasive tumor cells transfected with hNanos1 siRNA (10 5 cells) were placed in the upper compartment of the Transwell insert (Corning). For MMP inhibition experiments, the broad-spectrum synthetic hydroxamate MMP inhibitor BB-94 (Batimastat) (provided by British Biotech, Oxford, UK), with potent and specific activity against most of the major MMPs (MMP-1, -2, -3, -7, -9, -14), was added at 5 Â 10 À6 M to the cells in the upper compartment of the insert. The two compartments were separated by a porous filter (8 mm pore) coated with Matrigel (25 mg per filter). The chambers were incubated for 24 h at 37 1C. The filters were then fixed in methanol and stained with hematoxylin. Quantification of the invasion assay was performed by counting the number of cells at the lower surface of the filters (30 fields at 400-fold magnification).
Western blotting
Total proteins were extracted in RIPA buffer containing complete protease inhibitor cocktail (Roche diagnostics GmbH). For each sample, 250 ng or 10 mg total protein were separated on 12% SDS-polyacrylamide gel electrophoresis (PAGE) gels and transferred to a polyvinylidene fluoride membrane (NEN, Boston, MA, USA). The membranes were incubated with a mouse monoclonal antibody to Myc-tag (2 mg ml À1 , 9E10; Sigma) or a mouse monoclonal antibody to MT1-MMP (1 mg ml
À1
, clone 5H2; R&D Systems). The filters were then incubated with a horseradish peroxidase-conjugated swine anti-mouse (Dako, Glostrup, Denmark). Signals were detected with an enhanced chemiluminescence (ECL þ ) kit (Amersham Pharmacia Biotech, GE Healthcare, Buckinghamshire, UK). Subsequent detection of actin (using a rabbit antibody to actin, 0.8 mg ml À1 , clone A2066; Sigma) was performed on the same filters as a control.
MT1-MMP activity assay
Active MT1-MMP level was measured in DLD1 transfectant cultures treated with or without doxycycline with the MMP-14, Biotrak Activity Assay System (Amersham). 
